Associate Director, Quantitative Systems Pharmacologist jobs in United States
cer-icon
Apply on Employer Site
company-logo

Pfizer · 21 hours ago

Associate Director, Quantitative Systems Pharmacologist

Pfizer is a leading pharmaceutical company, and they are seeking a highly motivated individual to lead the development and application of Quantitative Systems Pharmacology models. The successful candidate will integrate and share data in a collaborative environment to enhance decision-making in drug discovery and development, particularly in the oncology therapeutic area.

BiotechnologyHealth CareMedicalPharmaceuticalPrecision Medicine
badNo H1Bnote

Responsibilities

Build and utilize QSP models of biological, physiological, and/or pathophysiological processes to evaluate novel targets, pathways, and drug candidates
Identification of appropriate quantitative approaches for MIDD activities
Work in close collaboration with biologists, clinicians, precision medicine scientists, clinical pharmacologists, pharmacometricians, QSP and nonclinical modelers, and other partner line colleagues to inform discovery and development programs and improve our understanding of disease mechanisms
Serve as QSP modeling & simulation expert in, or leader of, multidisciplinary project teams to solve challenging problems in drug discovery and development; contribute to preclinical and clinical study designs and mechanistic interpretation of data
Develop and/or utilize state-of-the-art mathematical tools to gain insight into causal relationships between individual components of targets, pathways, and systems-level responses
Analyze and interpret complex data sets in the context of disease mechanisms and pathways; develop a deep disease understanding and knowledge-base

Qualification

Quantitative Systems PharmacologyMathematical modelingDifferential equation-based modelsOncology experienceModelingSimulation packagesStatistical methodsCollaboration skillsCommunication skillsLeadership abilities

Required

Ph.D. in Applied Mathematics, Engineering, Physics, Pharmaceutical Sciences, or related disciplines with strong background in mathematical, statistical, and numerical methods with at least 1 year of experience
Experience in developing QSP and/or differential equation-based models of biological or physiological systems

Preferred

Experience (~ 2 years+) in applying QSP approaches to drug discovery and development programs in the pharmaceutical industry
Experience in Oncology and Immuno-Oncology therapeutic areas
Growing ability to be a strategic contributor or leader in support of MIDD
Deep understanding of theory, principles, and statistical aspects of mathematical modeling and simulation, including numerical methods, parameter estimation/optimization, ordinary differential equations (ODEs), and how these can be applied in the development of complex models of biological pathways and systems
Computational fluency and extensive, hands-on experience with one or more modeling and simulation packages or programming languages (e.g., MATLAB, R, Julia, SimBiology, C/C++)
Creative and innovative scientist who is passionate about developing a deep understanding of disease and disease mechanisms and who has experience working closely with biologists, clinical and nonclinical modelers, and clinical colleagues
Self-directed, independent, and highly motivated researcher who excels in a collaborative, multi-disciplinary team environment
Excellent oral and written communication skills
Primary authorship on relevant publications in peer-reviewed scientific journals

Benefits

Participation in Pfizer’s Global Performance Plan with a bonus target of 17.5% of the base salary
Eligibility to participate in our share based long term incentive program
401(k) plan with Pfizer Matching Contributions
Additional Pfizer Retirement Savings Contribution
Paid vacation
Holiday and personal days
Paid caregiver/parental and medical leave
Health benefits to include medical, prescription drug, dental and vision coverage

Company

Pfizer is a biopharmaceutical company that discovers, develops, and delivers medicines and vaccines.

Funding

Current Stage
Public Company
Total Funding
$38B
Key Investors
Starboard Value
2025-11-21Post Ipo Debt· $6B
2024-10-07Post Ipo Equity· $1B
2023-05-16Post Ipo Debt· $31B

Leadership Team

leader-logo
Albert Bourla
Chief Executive Officer
linkedin
leader-logo
Ian Read
Chief Executive Officer
linkedin
Company data provided by crunchbase